Page 1 of 1

JC virus urinary excretion and seroprevalence.....

Posted: Wed Jul 23, 2014 1:39 am
by MSUK
JC virus urinary excretion and seroprevalence in natalizumab-treated MS patients

The risk of developing progressive multifocal leukoencephalopathy (PML), as a consequence of infection/reactivation with JC virus (JCV), is consistent in natalizumab-treated multiple sclerosis (MS) patients, with 430 cases of PML reported so far.......... Read More - http://www.ms-uk.org/tysabri